The Effects of Remdesivir and Dexamethasone on Renal Sirtuin-1 Expression and Renal Function in Male Rats
-
Published:2023-05-11
Issue:
Volume:
Page:
-
ISSN:0273-2289
-
Container-title:Applied Biochemistry and Biotechnology
-
language:en
-
Short-container-title:Appl Biochem Biotechnol
Author:
Danaiyan Sepideh, Abbasi Mehran Mesgari, Raeisi Sina, Argani Hassan, Ghorbanihaghjo Amir, Shanehbandi Dariush, Roshangar Leila, Poursistany Haniyeh, Abedi Sara, Mohammadian Jamal, Bahremani Mona, Rashtchizadeh NaderehORCID
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,General Medicine,Bioengineering,Biotechnology
Reference21 articles.
1. Tarmahi, V., Afghan, M., Raeisi, S., YousefiNodeh, H. R., Tamaddon, M., Moahamadzadeh, F., Mohammadzadeh, N., & Ebadi, Z. (2021). The accuracy of enzyme-linked immunosorbent assay in the diagnosis of COVID-19 in Iranian children. International Journal of Pediatrics, 9(7), 13937–13945. 2. Rabby, M. I. I. (2020). Current drugs with potential for treatment of COVID-19: A literature review: Drugs for the treatment process of COVID-19. Journal of Pharmacy & Pharmaceutical Sciences, 23, 58–64. 3. Abd-Elsalam, S., Salama, M., Soliman, S., Naguib, A. M., Ibrahim, I. S., Torky, M., Abd El Ghafar, M. S., Abdul-Baki, E.A.-R.M., & Elhendawy, M. (2022). Remdesivir efficacy in COVID-19 treatment: A randomized controlled trial. The American Journal of Tropical Medicine and Hygiene, 106(3), 886. 4. de Oliveira Silva, N. A., de SeneAmâncio Zara, A. L., Figueras, A., & de Melo, D. O. (2021). Potential kidney damage associated with the use of remdesivir for COVID-19: Analysis of a pharmacovigilance database. Cadernos Saude Publica, 37, e00077721. 5. Marrone, A., Nevola, R., Sellitto, A., Cozzolino, D., Romano, C., Cuomo, G., Aprea, C., Schwartzbaum M. X. P., Ricozzi C., Imbriani. S. (2022). Remdesivir plus dexamethasone versus dexamethasone alone for the treatment of COVID-19 patients requiring supplemental O2 therapy: A prospective controlled non-randomized study. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America, 75(1):e403–e409
|
|